Concepedia

Author

Ettore Seregni

Fondazione IRCCS Istituto Nazionale dei TumoriORCID

Also Known As

Alessandra Alessi, Bruno Raggiunti, E SEREGNI, E Seregni, E. Seregni, Ettore C. Seregni, Ettore Cesare Seregni, Ettore Seregni, Harald Rimmele, Nicholas Reed

302

Publications

11K

Citations

50

H-Index

130

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei TumoriUniversity of MilanEuropean Institute of OncologyIstituti di Ricovero e Cura a Carattere Scientifico
ES

About

Ettore Seregni is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

29

62

3.5K

2

Health Sciences

15

20

987

3

Engineering

7

7

222

4

Public Health

4

4

104

5

Education

1

1

11

Ettore Seregni

×

120

Publications

9.4K

Citations

46

H-Index

YearCitations

Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors

Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin,

New England Journal of Medicine

2017

3K

Human Colorectal Cancer Cells Induce T-Cell Death Through Release of Proapoptotic Microvesicles: Role in Immune Escape

Veronica Huber, Stefano Fais, Manuela Iero,

Gastroenterology

2005

512

Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors

Emilio Bajetta, Leonardo Ferrari, Antonia Martinetti,

Cancer

1999

288

Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies

Furio Pacini, Fulvio Basolo, Rocco Bellantone,

Journal of Endocrinological Investigation

2018

211

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

Flavio Crippa, Ettore Seregni, Roberto Agresti,

European Journal of Nuclear Medicine and Molecular Imaging

1998

185

Independent Validation of Candidate Breast Cancer Serum Biomarkers Identified by Mass Spectrometry

Jinong Li, Rosaria Orlandi, Craig White,

Clinical Chemistry

2005

184

Minimally-invasive treatments for benign thyroid nodules: a Delphi-based consensus statement from the Italian minimally-invasive treatments of the thyroid (MITT) group

Enrico Papini, Claudio Maurizio Pacella, Luigi Solbiati,

International Journal of Hyperthermia

2019

184

5-fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors

Emilio Bajetta, Lorenza Rimassa, Carlo Carnaghi,

Cancer

1998

165

Axillary Lymph Node Staging in Breast Cancer by 2-Fluoro-2-deoxy-D-glucose-Positron Emission Tomography: Clinical Evaluation and Alternative Management

Marco Greco, Federica Crippa, Roberto Agresti,

JNCI Journal of the National Cancer Institute

2001

165

Radioembolization of hepatocarcinoma with 90Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology

Claudio Chiesa, Marco Maccauro, Carlo Spreafico,

European Journal of Nuclear Medicine and Molecular Imaging

2015

159

Page 1